Kerry Wentworth - Net Worth and Insider Trading

Kerry Wentworth Net Worth

The estimated net worth of Kerry Wentworth is at least $1 Million dollars as of 2024-12-27. Kerry Wentworth is the Chief Regulatory Officer of Flexion Therapeutics Inc and owns about 146,362 shares of Flexion Therapeutics Inc (FLXN) stock worth over $1 Million. Kerry Wentworth is also the VP, Reg Affairs & Clinical Ops of Agenus Inc and owns about 21 shares of Agenus Inc (AGEN) stock worth over $59. Details can be seen in Kerry Wentworth's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kerry Wentworth has not made any transactions after 2021-07-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kerry Wentworth

To

Kerry Wentworth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kerry Wentworth owns 3 companies in total, including Flexion Therapeutics Inc (FLXN) , Agenus Inc (AGEN) , and Nuvation Bio Inc (NUVB) .

Click here to see the complete history of Kerry Wentworth’s form 4 insider trades.

Insider Ownership Summary of Kerry Wentworth

Ticker Comapny Transaction Date Type of Owner
FLXN Flexion Therapeutics Inc 2021-07-19 Chief Regulatory Officer
AGEN Agenus Inc 2013-06-14 VP & Clinicial & Reg & & Quality
NUVB Nuvation Bio Inc 2020-05-23 Chief Regulatory Officer

Kerry Wentworth Latest Holdings Summary

Kerry Wentworth currently owns a total of 2 stocks. Among these stocks, Kerry Wentworth owns 146,362 shares of Flexion Therapeutics Inc (FLXN) as of July 19, 2021, with a value of $1 Million and a weighting of 100%. Kerry Wentworth also owns 21 shares of Agenus Inc (AGEN) as of July 20, 2006, with a value of $59 and a weighting of 0%.

Latest Holdings of Kerry Wentworth

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FLXN Flexion Therapeutics Inc 2021-07-19 146,362 9.12 1,334,821
AGEN Agenus Inc 2006-07-20 21 2.81 59

Holding Weightings of Kerry Wentworth


Kerry Wentworth Form 4 Trading Tracker

According to the SEC Form 4 filings, Kerry Wentworth has made a total of 2 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Flexion Therapeutics Inc is the sale of 3,944 shares on July 19, 2021, which brought Kerry Wentworth around $25,439.

According to the SEC Form 4 filings, Kerry Wentworth has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the sale of 0 shares on July 20, 2006, which brought Kerry Wentworth around $0.

Insider Trading History of Kerry Wentworth

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kerry Wentworth Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kerry Wentworth Ownership Network

Ownership Network List of Kerry Wentworth

No Data

Ownership Network Relation of Kerry Wentworth

Insider Network Chart

Kerry Wentworth Owned Company Details

What does Flexion Therapeutics Inc do?

Who are the key executives at Flexion Therapeutics Inc?

Kerry Wentworth is the Chief Regulatory Officer of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Strategy Officer Christina Willwerth , General Counsel Mark S. Levine , and Chief Financial Officer David Arkowitz .

Flexion Therapeutics Inc (FLXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Flexion Therapeutics Inc Insider Transactions

No Available Data

Kerry Wentworth Mailing Address

Above is the net worth, insider trading, and ownership report for Kerry Wentworth. You might contact Kerry Wentworth via mailing address: Agenus Inc., 3 Forbes Road, Lexington Ma 02421.

Discussions on Kerry Wentworth

No discussions yet.